Compare FENC & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENC | AZ |
|---|---|---|
| Founded | 1996 | 2018 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.3M | 228.5M |
| IPO Year | 2001 | N/A |
| Metric | FENC | AZ |
|---|---|---|
| Price | $7.86 | $6.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $15.00 | ★ $20.00 |
| AVG Volume (30 Days) | 118.3K | ★ 491.6K |
| Earning Date | 03-09-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $38,790,000.00 | $7,463,000.00 |
| Revenue This Year | N/A | $30.87 |
| Revenue Next Year | $70.78 | $480.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 41.45 |
| 52 Week Low | $4.68 | $5.00 |
| 52 Week High | $9.92 | $12.36 |
| Indicator | FENC | AZ |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 37.62 |
| Support Level | $7.65 | $5.90 |
| Resistance Level | $8.11 | $8.05 |
| Average True Range (ATR) | 0.26 | 0.48 |
| MACD | 0.02 | -0.21 |
| Stochastic Oscillator | 52.61 | 7.91 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.